Schnyder Corneal Dystrophy Treatment & Management

Updated: Jun 10, 2020
  • Author: Ahmed Farghaly Abdelhameed Omar, MD, PhD; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print

Medical Care

No local or systemic medical treatment is available to stop the progression of corneal lipid deposition or the alteration of serum cholesterol levels.


Surgical Care

Penetrating keratoplasty (PKP) can be performed successfully in those patients with advanced disease, but the dystrophy can recur in the graft. One study showed recurrence in 21% of eyes who underwent PKP. [3]

Phototherapeutic keratectomy can remove subepithelial crystals if they are causing decreased vision and glare, but it does not reduce panstromal haze. [6]


Long-Term Monitoring

Patients should receive follow-up care as needed.